TrialBritish journal of haematology2020

Pomalidomide plus low-dose dexamethasone in relapsed refractory multiple myeloma after lenalidomide treatment failure.

David S Siegel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.